A medicine that protects people from the HIV virus is used mostly by white people in Georgia, despite most new cases occurring among Black people, according to recently released data compiled at Emory ...
Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
Though Alpert Medical School may be small, the University's Center for AIDS Research is a national leader in HIV/AIDS research for marginalized populations, such as women, adolescents and incarcerated ...
In the 41-year HIV epidemic, no treatments have been approved to completely clear the virus largely because of its ability to live on in hidden form in the genomes of T cells. Now, researchers say an ...
NEW YORK (PIX11) — A new kind of HIV prevention is making it easier for those at risk to stay protected, thanks to a twice-yearly injection now available at Northwell Health. Instead of remembering a ...
Hot on the heels of Pfizer’s access accord, GSK’s ViiV Healthcare is teaming up with its old friend the Medicines Patent Pool (MPP) to broaden access to its latest HIV prevention med. Specifically, ...
It will be a little while before Merck finds out how well its long-acting HIV drug prevents infection, but in the meantime, the company is revealing phase 2 data—and they’re promising. Two dose levels ...
The Infectious Diseases group at Cayuga Health offers treatment for hepatitis B and C as well as HIV treatment including Pre-exposure prophylaxis, a highly effective medicine for preventing HIV when ...
In the latest battle over access to medicines, Colombian authorities have decided to issue a compulsory license for a needed HIV treatment, a step that underscores ongoing friction between the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback